Trials / Completed
CompletedNCT04990089
VIVO European Observational Registry
VIVO in a Practical Clinical Experience
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 125 (actual)
- Sponsor
- Catheter Precision. Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center, observational registry conducted in Europe and the UK to prospectively review VIVO in a clinical setting in 125 patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VIVO | VIVO is a per-procedural planning tool designed to non-invasively identify the origin of a ventricular arrhythmia. |
Timeline
- Start date
- 2021-10-21
- Primary completion
- 2024-06-28
- Completion
- 2024-09-28
- First posted
- 2021-08-04
- Last updated
- 2025-01-31
Locations
8 sites across 5 countries: Ireland, Italy, Netherlands, Portugal, United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04990089. Inclusion in this directory is not an endorsement.